Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Expanded safety and acceptability of the candidate vaginal microbicide CarraguardĀ® in South Africa.

Carraguard Phase II South Africa Study Team.

Contraception. 2010 Dec;82(6):563-71. doi: 10.1016/j.contraception.2010.04.019. Epub 2010 May 26. Erratum in: Contraception. 2011 Nov;84(5):539. Williams, Manuela M [corrected to Williams, Maria Manuela].

2.

Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.

Turner AN, De Kock AE, Meehan-Ritter A, Blanchard K, Sebola MH, Hoosen AA, Coetzee N, Ellertson C.

J Clin Epidemiol. 2009 Jul;62(7):759-65. doi: 10.1016/j.jclinepi.2008.07.011. Epub 2008 Nov 14.

PMID:
19013762
3.

Microbicide trials for preventing HIV/AIDS in South Africa: phase II trial partricipants' experiences and psychological needs.

Pistorius AG, van de Wijgert JH, Sebola M, Friedland B, Nagel E, Bokaba C, Hoosen AA.

SAHARA J. 2004 Aug;1(2):78-86.

PMID:
17601013
4.

Phase III microbicide trial methodology: opinions of experienced expanded safety trial participants in South Africa.

van de Wijgert J, Jones H, Pistorius A, de Kock A, Sebola M, Friedland B, Hoosen A, Coetzee N.

SAHARA J. 2005 Nov;2(3):311-9.

PMID:
17600973
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk